Union Health Minister J P Nadda assured that the US exiting WHO will not affect India's health programs. He emphasized India's self-reliance and strong partnerships in global health initiatives.
Union Health Minister J P Nadda has assured that India’s ongoing health programs in collaboration with the World Health Organization (WHO) will remain unaffected despite the United States’ recent decision to exit the global health body. Addressing a press conference on the progress of the National Health Mission (NHM), he emphasized India’s self-reliance in healthcare and its strong partnership with WHO, asserting that no disruptions will occur.
Nadda reiterated that India is not dependent on any single international entity for its healthcare initiatives. “Our projects and programs will continue. As far as health is concerned, we are not dependent on anybody,” he stated. India’s robust healthcare policies and financial commitment ensure stability in its medical initiatives, regardless of global political changes.
The health minister also highlighted that India is one of the significant contributors to WHO. This partnership, he noted, is based on mutual collaboration rather than dependency, and India will continue to engage in global health initiatives while strengthening its domestic healthcare framework.
Since 2014, India has seen remarkable advancements in healthcare under the NHM, with several new and strengthened initiatives. Some of the major achievements include:
According to Nadda, the central release under NHM has grown by 185% since 2014, showcasing the government’s commitment to healthcare development. The Union Budget, scheduled for release soon, is expected to further bolster financial support for health programs.
The government has shifted its focus from curative healthcare to a more comprehensive approach, encompassing preventive, curative, and rehabilitative healthcare services. This shift is evident in the rapid expansion of health initiatives such as Ayushman Arogya Mandirs (AAM), which witnessed a surge in annual footfall from 13.49 crore in 2019-20 to 121.03 crore in 2023-24.
Additionally, teleconsultation services have seen a significant rise, with figures increasing from 26 lakh consultations to 11.83 crore within the same period. The government’s Free Drugs and Diagnostics Service Initiative has been enhanced to ensure transparency in medicine availability, with mandatory public displays of drug stocks at healthcare institutions.
India has had a longstanding association with WHO, engaging in multiple collaborative projects to improve public health standards. Despite the US decision to exit WHO, Nadda assured that existing partnerships between India and WHO will continue seamlessly. WHO plays a crucial role in technical support, research collaborations, and policy advisories, but India has built enough capacity to sustain its health programs independently.
One of the notable advancements in India’s healthcare landscape is the expansion of dialysis services under the PMNDP, which has benefited over 4.53 lakh patients in FY 2023-24. This initiative provides free dialysis to kidney patients, reducing financial burdens on families.
Another significant move by the government is the proposed rollout of the HPV vaccine against cervical cancer as a pilot project. Health Secretary Punya Salila Srivastava stated that the modalities and strategies for the vaccine rollout are being finalized. This initiative aims to reduce cervical cancer incidences in India, a leading cause of cancer-related deaths among women.
The government’s proactive measures in expanding healthcare services indicate that India is well-prepared to handle any challenges arising from global policy shifts. Key factors ensuring stability include:
The US decision to exit WHO will have no impact on India’s ongoing health programs, as assured by Health Minister J P Nadda. India’s self-reliance, growing healthcare infrastructure, and financial commitment ensure that critical health initiatives will continue uninterrupted. With strong collaborations, technological advancements, and policy-driven approaches, India is set to achieve further progress in the healthcare sector while maintaining its global leadership in public health initiatives.
In a recent address to Congress on March 4, 2025, President Donald Trump stated that…
Scientists have recently uncovered a hidden immune system part that could revolutionize how we combat…
Expired medications turning toxic pose a serious threat to your health, and certain drugs like…
In a significant move, Delhi Health Minister Pankaj Singh announced that 250 Mohalla Clinics will…
The Indian pharma sector’s value can grow 150% to ₹10 lakh crore by partnering with…
The rise of Attention Deficit Hyperactivity Disorder (ADHD) cases in young adults has become a…